Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.com
Google Alert - NSCLC AND EMA AND Europe
Get the latest updates from Google Alert - NSCLC AND EMA AND Europe directly as they happen.
Follow now 139 followers
Latest posts
Last updated 10 months ago
Europe Oncology Market Size, Share & Trends, 2033
10 months ago
The European Medicines Agency (EMA) has also expedited approvals for breakthrough oncology...
FDA approves diagnostic tool for MET-targeted lung cancer therapy - Pharmafile
10 months ago
Moleculin Biotech has received approval from the European Medicines Agency (EMA) to...
Opdivo Perioperative Regimen Approved in Europe for PD-L1-Positive NSCLC Patients
10 months ago
non-small cell lung cancer · PD-L1 Biomarkers · Europe. We recommend. EMA's...
Rozanolixizumab for gMG Approved in Japan for Self-Administration
10 months ago
https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3 ... lung cancer (NSCLC) with high c-met protein overexpression. AbbVie ...
Reirradiation: 'Attractive' Option in Recurrent NSCLC - Medscape
10 months ago
Why Lung Cancer Screening Is Not for Everyone · Two Lung Cancer...
CT Follow-up Strategy Optimises Lung Cancer Screening - Medscape
10 months ago
Non-Small Cell Lung Cancer (NSCLC) Imaging · Survivorship ... Two Lung Cancer...
April 2025 — CDMO Opportunities And Threats Report - Bioprocess Online
10 months ago
... (NSCLC) at high risk of recurrence and no epidermal ... EMA...
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
10 months ago
Company received approval from European Medicines Agency (EMA) for CLN-978; Phase 1...
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
10 months ago
... NSCLC treatment, with results to be presented at ASCO 2025. The...
Top 20 Lung Cancer Drugs Market Analysis and Segment Forecasts to 2030
10 months ago
... EU, and select Asia-Pacific regions. Agencies like the U.S. FDA and...
European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue
10 months ago
Plus, news about NewAmsterdam, C4 Therapeutics, Vivo Capital, and Arcus Biosciences: EMA...
Johnson & Johnson submits application for subcutaneous Rybrevant dosing - PharmaTimes
10 months ago
Janssen-Cilag International NV, a Johnson & Johnson company, has submitted an application...